MEDP Stock Plunges 15.9% on Guidance Misstatement; Securities Fraud Lawsuit Filed
Medpace Holdings faces securities lawsuit over allegedly inflated Q4 2025 guidance. Stock dropped 15.9% after actual book-to-bill ratio fell short of management projections.
MEDPsecurities fraudclass action lawsuit